Wegovy is a self-injectable drug administered subcutaneously (under the skin) once a week with a single-dose, pre-filled pen injector
Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: a randomised, placebo-controlled, multiple-ascending-dose phase 1b trial
This systemic effect simply cannot occur with topical application
Accessed 3 January 2025
Urinary frequency may change due to improved glycaemic control reducing osmotic diuresis, gastrointestinal side effects affecting hydration, or weight loss alleviating bladder pressure
Following our previously reported protocols with the NanoBiT tethering strategy 11 , the structures of retatrutideGLP-1RG s , retatrutideGIPRG s and retatrutideGCGRG s were determined using the single-particle cryo-EM with overall resolutions of 2.68 , 3.26 and 2.84 , respectively (Fig